Not only has Su Metcalfe’s treatment succeeded in early trials, it involves zero drugs and no side effects—and it could begin human trials as soon as 2020.
After Her Years of Research, a Cambridge Scientist Could Be on the Verge of Curing Multiple Sclerosis
Posted in biotech/medical